Company intelligence / Profile preview

Precise Health

Epalinges, Vaud, Switzerlandprecisehealthcare.org ↗

Ownership: Private
Development stage: Commercial

Overview

Precise Health is developing a personalized, AI-driven bacteriophage therapy platform to replace broad-spectrum antibiotics, initially targeting inflammatory skin diseases such as acne and atopic dermatitis. The company is preparing animal studies for bacterial sepsis. No clinical results have been published yet; the company remains preclinical with market launch preparations underway.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Bacteriophage therapyBiologic
Industry: Biotech

Beyond the preview

Go deeper on Precise Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Precise Health.

Explore the full profile